CONSENSI (amlodipine besylate/celecoxib)
CALCIUM CHANNEL BLOCKERS·CONCOMITANT HYPERTENSION AND OSTEOARTHRITIS
BURKE THERAPEUT
Indication
Concomitant hypertension and osteoarthritis
Concomitant hypertension and osteoarthritis is a dual-disease clinical state characterized by the coexistence of chronic systemic arterial hypertension and degenerative joint disease within an individual, predominantly affecting aging adults. Read more about Concomitant hypertension and osteoarthritis
1 drugs 1 manufacturers
Drugs that treat it
Common Concomitant hypertension and osteoarthritis therapies.
Filter & compare in the drug finder →Opens the drug finder with Concomitant hypertension and osteoarthritis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonConcomitant hypertension and osteoarthritis is a dual-disease clinical state characterized by the coexistence of chronic systemic arterial hypertension and degenerative joint disease within an individual, predominantly affecting aging adults.
Affecting both the cardiovascular and musculoskeletal systems, the comorbidity features sustained elevation of systemic vascular resistance alongside progressive articular cartilage degradation, subchondral bone remodeling, synovial inflammation, and joint pain.
Pathophysiologically, systemic vascular dysfunction and endothelial impairment can exacerbate subchondral bone ischemia and intraosseous hypertension, while shared risk factors such as advanced age, obesity, and low-grade systemic inflammation accelerate structural joint deterioration and cardiovascular strain.
This clinical pairing presents unique therapeutic challenges, as common analgesic strategies may compromise blood pressure control and elevate cardiovascular risk.
- polyu.edu.hk
Concomitant hypertension and osteoarthritis is a dual-disease clinical state characterized by the coexistence of chronic systemic arterial hypertension and degenerative joint disease within an individual, predominantly affecting aging adults Affecting both the cardiovascular and musculoskeletal systems, the comorbidity features sustained elevation of systemic vascular resistance alongside progressive articular cartilage degradation, subchondral bone remodeling, synovial inflammation, and joint p...
- ajol.info
Concomitant hypertension and osteoarthritis is a dual-disease clinical state characterized by the coexistence of chronic systemic arterial hypertension and degenerative joint disease within an individual, predominantly affecting aging adults
- nih.gov
Affecting both the cardiovascular and musculoskeletal systems, the comorbidity features sustained elevation of systemic vascular resistance alongside progressive articular cartilage degradation, subchondral bone remodeling, synovial inflammation, and joint pain
- nih.gov
This clinical pairing presents unique therapeutic challenges, as common analgesic strategies may compromise blood pressure control and elevate cardiovascular risk
Personalize your experience
Follow Concomitant hypertension and osteoarthritis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.